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Abstract. 
 
p10/NTF2 is a nuclear transport carrier that
mediates the uptake of cytoplasmic RanGDP into the
nucleus. We constructed a point mutant of p10, D23A,
that exhibited unexpected behavior both in digitonin-
permeabilized and microinjected mammalian cells.
D23A p10 was markedly more efﬁcient than wild-type
(wt) p10 at supporting Ran import, but simultaneously
acted as a dominant-negative inhibitor of classical nu-
clear localization sequence (cNLS)-mediated nuclear
 
import supported by karyopherins (Kaps) 
 
a
 
 and 
 
b
 
1.
Binding studies indicated that these two nuclear trans-
port carriers of different classes, p10 and Kap-
 
b
 
1, com-
pete for identical and/or overlapping binding sites at
the nuclear pore complex (NPC) and that D23A p10
has an increased afﬁnity relative to wt p10 and Kap-
 
b
 
1
for these shared binding sites. Because of this increased
afﬁnity, D23A p10 is able to import its own cargo
(RanGDP) more efﬁciently than wt p10, but Kap-
 
b
 
1
can no longer compete efﬁciently for shared NPC dock-
ing sites, thus the import of cNLS cargo is inhibited. The
competition of different nuclear carriers for shared
NPC docking sites observed here predicts a dynamic
equilibrium between multiple nuclear transport path-
ways inside the cell that could be easily shifted by a
transient modiﬁcation of one of the carriers. 
Key words: nuclear transport • nuclear pore complex
• p10 • NTF2 • karyopherin
 
Introduction
 
The p10 protein was first identified as playing a role in nu-
clear transport by the demonstration that it was a neces-
sary component of the cytosol used to support classical
nuclear localization sequence (cNLS)
 
1
 
-mediated nuclear
import in digitonin-permeabilized cells (Moore and Blo-
bel, 1994). This protein was purified from 
 
Xenopus
 
 cytosol
on the basis of its ability to stimulate nuclear import in
permeabilized cells (when added with Ran, Kap-
 
a
 
, and
Kap-
 
b
 
1) and named p10 because of its migration pattern
on SDS-PAGE gels. The predicted molecular mass of hu-
man p10 is 14 kD and p10 appears to exist as a homodimer
(Moore and Blobel, 1994; Bullock et al., 1996; Paschal et
al., 1996). p10 binds RanGDP with high affinity, but has
almost no affinity for RanGTP (Paschal et al., 1996; Stew-
art et al., 1998).
The identity of p10 as a nuclear import factor was later
verified by the observation that HeLa cytosol passed over
a p62 (a nuclear pore complex [NPC] protein) column
showed diminished capacity for supporting cNLS cargo
nuclear import in permeabilized cells (Paschal and Ger-
ace, 1995). The protein that reconstituted this loss of activ-
ity was purified from human cytosol, found to be the
human homologue of p10, and named NTF (nuclear trans-
port factor)2. In addition to p62, p10/NTF2 has been
shown to interact with additional members of the p62 fam-
ily of NPC proteins from both vertebrates and yeast, the
so-called repeat-containing nucleoporins (Nups), or repeat
Nups (Clarkson et al., 1996; Hu et al., 1996; Nehrbass and
Blobel, 1996). Each of these repeat Nups contain the re-
peat motif FG (PheGly), which is often found as part of a
larger repeat motif such as GLFG or FXFG (for a review
see Ryan and Wente, 2000). Members of the Kap-
 
b
 
 super-
family also interact with these repeat Nups, and it has been
proposed that this family of NPC proteins provide many
or most of the docking sites for the Kap-
 
b
 
 class of nuclear
transport carriers as they move through the NPC (Radu et
al., 1995a,b). One current model for nuclear transport is
that nuclear carriers move through the NPC by repeated
association–dissociation reactions with NPC proteins, a
process that has been called “facilitated diffusion” and
that appears not to require an energy source (Kose et al.,
1997; Ribbeck et al., 1998; Schwoebel et al., 1998; En-
glmeier et al., 1999; Talcott and Moore, 1999).
One known function of p10 is to serve as a nuclear trans-
port carrier to import RanGDP into the nucleus from the
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cytoplasm (Ribbeck et al., 1998; Smith et al., 1998). Ran is
only 25 kD and thus below the diffusion limit of the NPC,
yet at steady-state the cellular distribution of Ran is 
 
z
 
85%
in the nucleus, with the rest in the cytoplasm (Ren et al.,
1993). RCC1, the Ran guanine nucleotide exchange factor
(GEF), is also found in the nucleus, but the Ran GTPase
activating protein (GAP) is found in the cytoplasm, either
soluble or bound on the cytoplasmic filaments of the NPC
(Ohtsubo et al., 1989; Matunis et al., 1996; Mahajan et al.,
1997). This differential localization of Ran’s GAP and
GEF is thought to keep RanGTP at a low concentration in
the cytoplasm, but abundant in the nucleoplasm (Görlich
et al., 1996).
All Ran-dependent nuclear transport pathways de-
scribed thus far utilize a member of the Kap-
 
b
 
/importin 
 
b
 
superfamily as a nuclear transport receptor/carrier. These
Kap-
 
b
 
 family members either bind a nuclear localization
sequence (NLS)- or nuclear export sequence (NES)-con-
taining cargo directly, or via an adaptor protein such as
Kap-
 
a
 
 in the cNLS import pathway (for a review see Na-
kielny and Dreyfuss, 1999). In addition to binding their
specific cargo, most (if not all) of the proteins in this family
also contain a Ran binding site and preferentially bind
RanGTP rather than RanGDP (Rexach and Blobel, 1995;
Fornerod et al., 1997; Görlich et al., 1997). This Ran bind-
ing is key to the assembly and disassembly of Kap-
 
b
 
–con-
taining transport complexes. Export complexes require
high RanGTP to assemble, like in the nucleus, and dis-
assemble when RanGTP is low, like in the cytoplasm.
Conversely, import complexes will only assemble when
RanGTP is low and disassemble when RanGTP is high
(Rexach and Blobel, 1995; Görlich et al., 1996; Floer et al.,
1997; Izaurralde et al., 1997; Kutay et al., 1997a, 1998;
Floer and Blobel, 1999).
The p10-mediated accumulation of Ran inside the nu-
cleus requires the GEF activity of RCC1, to generate
RanGTP, in whole cells and the addition of GTP to per-
meabilized cells (Ribbeck et al., 1998; Smith et al., 1998).
The evidence suggests that the free GTP is used during the
RCC1-stimulated conversion of RanGDP to RanGTP to
trigger Ran’s release from p10 inside the nucleus, rather
than to power movement of the p10–RanGDP complex
through the NPC. Also, the addition of Kap-
 
b
 
 family
members has been shown to stimulate the p10-mediated
accumulation of Ran inside the nucleus (Ribbeck et al.,
1998). It has been proposed that this is due to binding of
nuclear RanGTP by Kap-
 
b
 
 family members inside the nu-
cleus, raising Ran’s effective size above 25 kD and pre-
venting its diffusion back out of the nucleus. However, the
mechanism by which a p10–Ran complex (or any transport
complex) moves through the NPC and exactly which NPC
proteins it associates with are unknown.
In
 
 Saccharomyces cerevisiae
 
, the NTF2 gene is an essen-
tial gene, though it was later demonstrated that overex-
pressing the Ran homologue (GSP1) in these cells would
compensate for an NTF2 deletion (Corbett and Silver,
1996; Nehrbass and Blobel, 1996; Wong et al., 1997). Con-
sistent with this, increasing the concentration of Ran in an
in vitro nuclear import assay in permeabilized cells de-
creases the need for p10 to support the nuclear import of a
cNLS cargo (Paschal et al., 1997). Increasing Ran’s con-
centration is thought to increase the amount of Ran that
 
enters the nucleus by p10-independent mechanisms, such
as diffusion, thereby decreasing the need for active nuclear
import of Ran mediated by p10.
With the goal of examining how a nuclear transport car-
rier moves through the NPC, we have generated several
point mutants of p10. Unexpectedly, we have engineered a
mutant p10, D23A, that is more efficient at low concentra-
tions than wild-type (wt) p10 at mediating the nuclear im-
port of its own cargo (RanGDP), but it is a dominant-neg-
ative inhibitor of cNLS import. We show that this is due to
a change in the relative affinities of p10 and Kap-
 
b
 
1 for the
NPC, and we speculate as to how a similar, naturally oc-
curring change in affinity of a nuclear transport carrier for
the NPC could alter its function in vivo.
 
Materials and Methods
 
Vector Construction and Site-directed Mutagenesis
 
To make FLAG-tagged p10, p10 was cloned from pTACTL7 (a gift
from U. Grundmann, Behringwerke, Marburg, Germany) into
pCEP4FLAG(EBNA) using PCR and incorporating HindIII and XhoI
sites. Then, standard DNA purification, digestion, and ligation procedures
were performed. For His-tag incorporation, FLAG–p10 was subcloned
into the pRSET expression vector (Invitrogen), by the method described
above, and incorporating KpnI and EcoRI sites. Site directed mutagenesis
was performed on pRSET His–FLAG–p10 using a PCR-based strategy
using Pfu enzyme from Stratagene, according to their instructions. Both
wt and mutated sequences were confirmed by DNA sequencing. The Kap-
 
b
 
1(45–462) fragment was obtained by PCR of the DNA corresponding to
amino acids 45–462 of Kap-
 
b
 
1 from pGEX4T-NTF97 (a gift from Steve
Adam, Northwestern University Medical School, Chicago, IL) and placed
in the pET30 Ek/LIC vector (which will add both NH
 
2
 
-terminal His and S
tags) by the method suggested by the manufacturer (Novagen).
 
Purification of Recombinant Proteins
 
pRSET–FLAG–p10-expressing wt and mutant p10s were transformed
into the BL21 (DE3)-Rep 4 strain. The cells were grown in Luria broth
(LB) containing 100 
 
m
 
g/ml ampicillin and 50 
 
m
 
g/ml kanamycin to an opti-
cal density at 600 nm (OD
 
600
 
) of 0.6, and then they were induced by the
addition of 1 mM isopropyl-
 
b
 
-thioglactoside (IPTG) for 3 h at 37
 
8
 
C. Bac-
teria were washed and lysed in a French pressure cell in 20 mM Hepes-
KOH, pH 7.3, 500 mM potassium acetate, 60 mM imidazole, and 10 mM
2-mercaptoethanol (homogenization buffer) containing 1 mM PMSF and
centrifuged at 250,000 
 
g
 
 for 90 min at 4
 
8
 
C in a Ti70 rotor (Beckman
Coulter). The supernatant was incubated for 2 h at 4
 
8
 
C with 1 ml nickel-
agarose (QIAGEN) equilibrated in homogenization buffer. The resin was
washed with 60 ml homogenization buffer and eluted with 5 ml homogeni-
zation buffer containing 400 mM imidazole. The column eluate was dia-
lyzed against buffer A (20 mM Hepes-KOH, pH 7.3, 100 mM potassium
acetate, 1 mM DTT). Ran and Kaps-
 
a
 
2 and -
 
b
 
1 were purified, as de-
scribed (Schwoebel et al., 1998), from expression vectors obtained from
Mark Rush (New York University Medical School, New York, NY), Ag-
nus Lamond (EMBL, Heidelberg, Germany), and Dirk Görlich (Zentrum
für Molekulare Biologie der Universität Heidelberg, Heidelberg, Ger-
many), respectively.
Kap-
 
b
 
1(45–462) purification was performed as described for recombi-
nant FLAG p10, except that the homogenization buffer was 50 mM Tris-
HCl, pH 7.4, 200 mM NaCl, 15 mM 2-mercaptoethanol. Bound Kap-
 
b
 
1(45–462) was eluted from the nickel resin with sequential elutions of 20,
40, 100, and 200 mM imidazole in homogenization buffer. The eluates
were separated on 10% SDS-PAGE gels and those containing Kap-
 
b
 
1
(45–462) were pooled and dialyzed against buffer A.
 
Permeabilized Cell Assays
 
Nuclear import assays were performed as described (Moore and Blobel,
1992; Schwoebel et al., 1998). In brief, buffalo rat liver (BRL) or HeLa
cells were washed once with cold transport buffer (TB, which contains 20
mM Hepes-KOH, pH 7.3, 110 mM potassium acetate, 2 mM magnesium
acetate, 1 mM EGTA, 2 mM DTT), and permeabilized with 35 
 
m
 
g/ml dig- 
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itonin (Calbiochem) in TB for 5 min on ice. The permeabilized cells were
then washed and incubated with 40 
 
m
 
l of an import mix (in TB) containing
the components listed in each figure legend. Permeabilized cells were in-
cubated at room temperature before washing and fixing. Samples were
observed and quantitated (Schwoebel et al., 1998) and 
 
Xenopus
 
 ovarian
cytosol was prepared as described (Moore and Blobel, 1992).
To observe FLAG-tagged p10 interactions with the nuclear envelope
of the permeabilized cells, the permeabilized cells were incubated with
0.25–0.5 
 
m
 
M (dimer) p10 (wt or mutant) in TB containing 2 mg/ml BSA
for 20 min at room temperature. Cells were washed twice with 1 ml of TB,
fixed, and processed for immunofluorescence microscopy with an anti-
FLAG antibody.
 
Overlay Assays
 
The Nup98 overlay assay was performed as described (Radu et al., 1995b),
except that the nitrocellulose was overlaid with 0.5 
 
m
 
M p10 (dimer) in TB
containing 2% gelatin and 0.2% Tween 20, and the p10 binding was de-
tected with an anti-Express tag antibody (Invitrogen).
[
 
a
 
-
 
32
 
P] GTP (3,000 Ci/mmol) (NEN Life Science Products) was con-
verted into [
 
a
 
-
 
32
 
P]GDP by incubation with glucose/hexokinase, and Ran
was loaded with hot nucleotide, as described (Schwoebel et al., 1998).
Each wt or mutant p10 in 100 
 
m
 
l overlay buffer (20 mM MOPS, pH 7.1,
100 mM potassium acetate, 5 mM magnesium acetate, 1 mM DTT, 0.5%
BSA, and 0.05% Tween 20) was dotted onto 0.45-
 
m
 
m nitrocellulose filters
using a Minifold II slot-blot apparatus (Schleicher & Schuell, Inc.). Nitro-
cellulose pieces were incubated 30 min with 7 
 
3 
 
10
 
6
 
 cpm [
 
a
 
-
 
32
 
P]RanGTP
or [
 
a
 
-
 
32
 
P]RanGDP in 10 ml overlay buffer at room temperature. Blots
were washed five times with overlay buffer and exposed to film.
 
Preparation of Fluorescent Import Substrates
 
The TRITC–BSA–NLS conjugate was prepared as described (Moore and
Blobel, 1992). The NLS peptide (CYTPPKKKRKV) contains the NLS of
the SV40 T antigen (Lanford et al., 1986). RanGDP was labeled at a 1:1
molar ratio with fluorescein-5-maleimide (Molecular Probes) in 20 mM
Tris-HCl, pH 7.5, 150 mM NaCl, and 2 mM MgCl
 
2
 
 for 2 h on ice, followed
by the addition of 2-mercaptoethanol to a final concentration of 50 mM.
Uncoupled fluorescein was removed by passing the sample over a Nap-5
column (Amersham Pharmacia Biotech) equilibrated with buffer A con-
taining 2 mM magnesium acetate (Buffer B). FITC–RanGDP was stored
at –80
 
8
 
C in single use aliquots.
 
Microinjection Studies
 
HeLa cells were injected with proteins at the concentrations indicated in
the figure legends. Before injection, all protein injection mixtures were
brought to equal volume with Buffer B and centrifuged at 14,000 
 
g
 
 for 30
min at 4
 
°
 
C. After injections, cells were incubated for 5 min at room tem-
perature and then fixed in 3% paraformaldehyde in PBS for 15 min on ice.
 
Results
 
To learn more about the cellular functions of p10, three
point mutants of human p10 (E42D, Y19A, and D23A)
were created by site-directed mutagenesis. Amino acids in
the p10 sequence were selected for mutagenesis based on
their position in the crystal structure of p10 (Bullock et al.,
1996) and their conservation across species (Katahira et
al., 1999). wt and mutant p10s were expressed and purified
using an 
 
Escherichia coli 
 
expression vector that adds both
a FLAG- and His- tag to the p10 protein. As shown in Fig.
1, all of the expressed and purified recombinant p10s ap-
peared as single bands by Coomassie blue staining of an
SDS-PAGE gel. The addition of the tags raised the pre-
dicted monomeric molecular mass of p10 from 14 to 21
kD, but this increase in mass was found to diminish only
slightly the ability of wt p10 to stimulate the nuclear im-
port of BSA–NLS in digitonin-permeabilized cells (data
not shown).
The ability of FLAG–p10 to support nuclear accumula-
tion of Ran in digitonin-permeabilized cells is shown in
Fig. 2. In these experiments, FITC–RanGDP was added to
the permeabilized cells, either alone or with p10 and vari-
ous additions. After washing and fixation, the nuclear ac-
cumulation of Ran was assessed and quantitated by fluo-
rescence microscopy. In experiments not shown, the
ability of FITC–RanGDP to support nuclear import of
BSA–NLS in permeabilized cells was found to be unaf-
fected by its labeling by fluorescein-maleimide, indicating
that Ran was not damaged by the labeling procedure.
Confirming the results of others (Ribbeck et al., 1998;
Smith et al., 1998), we found that p10 would support the
nuclear accumulation of Ran in permeabilized cells, but
only under certain conditions. In the presence of p10,
FITC–RanGDP, and an energy mix (consisting of GTP
and ATP plus an ATP-regenerating system), nuclear accu-
mulation of the added Ran was observed in 
 
z
 
30% of the
permeabilized cells (Fig. 2 A, top row). If the energy mix
was omitted, this accumulation was not observed in any of
the cells (Fig. 2 A, second row).
If Kap-
 
b
 
1 was also added, the percentage of cells show-
ing nuclear accumulation of Ran could be greatly in-
creased, with essentially 100% of the cells showing nuclear
accumulation (Fig. 2, A and B). In contrast, substitution of
a truncated Kap-
 
b
 
1 lacking its Ran binding domain, Kap-
 
b
 
1 (45–462) (Kutay et al., 1997b), for the full-length Kap-
 
b
 
1 did not result in a stimulation of Ran nuclear accumula-
tion (Fig. 2 A, bottom right) and in fact appeared to block
the Ran import obtained when no Kap-
 
b
 
1 was added (Fig.
2 A, top right). Fig. 2 B shows the quantitation of the nu-
clear import of Ran, obtained under various conditions,
and confirms a dependence on added GTP and a further
stimulation of nuclear accumulation by Kap-
 
b
 
1. Another
nuclear transport factor, Kap-
 
a
 
2, which doesn’t bind
RanGTP, was found to be unable to stimulate the nuclear
accumulation of Ran (Fig. 2 B). As previously proposed
(Ribbeck et al., 1998; Smith et al., 1998), we believe it
likely that both the GTP and Kap-
 
b
 
1 are being used to
stimulate the nuclear accumulation of Ran, rather than be-
ing required directly for movement of the p10–Ran com-
plex across the NPC.
We had anticipated that a mutation in p10 would either
have no effect on its biological activity or decrease it. To
our surprise, we found that at low concentrations D23A
p10 was markedly more efficient at supporting the nuclear
accumulation of Ran than wt p10 (Fig. 2 C). In contrast, the
mutant E42D p10 was unable to support Ran nuclear im-
port. The reason for the observed inability of E42D p10 to
support Ran import can be explained by the results shown
in Fig. 3. The binding of wt and mutant p10s to RanGDP or
Figure 1. Purified recombi-
nant p10 proteins. Purified
recombinant p10 proteins
were run on a 15% SDS-
PAGE gel and stained with
Coomassie blue. wt p10 has
an apparent molecular mass
of 10 kD, but a predicted mo-
lecular mass of 14 kD.
Tagged p10s have an Mr closer to their true predicted mass of 21
kD. Lanes: 1, untagged wt p10; 2, wt p10; 3, E42D p10; 4, Y19A
p10; and 5, D23A p10. 
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RanGTP was analyzed by Ran overlay assays (Fig. 3 A).
Of the p10 mutants tested, only D23A p10 retained its abil-
ity to bind RanGDP. Neither E42D nor Y19A p10 were
observed to bind RanGDP in this assay. This inability to
bind RanGDP explains why E42D and Y19A p10 are also
unable to support Ran’s nuclear accumulation (Figs. 2 C
and 3 B). The crystal structure of p10 bound to RanGDP
(Stewart et al., 1998) reveals that p10 amino acid E42 forms
a salt bridge between Ran and p10 necessary for the stabili-
zation of RanGDP binding. A different mutation in this
amino acid, E42K, was shown previously to abolish Ran
binding to p10, without altering the overall structure of p10
(Clarkson et al., 1997). In contrast, amino acids D23 and
Y19 are not among the amino acids directly implicated in
RanGDP binding by p10, although all of our data suggests
that the Y19A mutation results in profound structural
changes throughout the p10 molecule (see below).
Surprisingly, we found that although D23A p10 could
support the nuclear import of Ran, this mutant p10 had a
marked inhibitory effect on the import of a cNLS cargo
(Fig. 4). In Fig. 4 A, the import of BSA–NLS into the nu-
clei of digitonin-permeabilized BRL cells was supported
by 
 
Xenopus
 
 cytosol as a source of transport factors plus
energy. This import substrate contains peptides containing
the cNLS of the SV40 T antigen coupled to rhodamine-
labeled BSA (Moore and Blobel, 1992). The 
 
Xenopus
 
 cy-
tosol used is known to contain endogenous p10 that is
functional in permeabilized mammalian cells (Moore and
Blobel, 1994). wt p10 had no effect on the nuclear import
of BSA–NLS when added to the cytosol at 3 
 
m
 
M (Fig. 4
A). In marked contrast, the addition of D23A p10 at the
same concentration severely inhibited the nuclear import
of BSA–NLS.
Fig. 4 B shows that D23A also inhibits BSA–NLS im-
port in a reaction supported with purified, recombinant
transport factors (Kap-
 
b
 
2, Kap-
 
a
 
2, and Ran) rather than
cytosol. Because we only wanted to observe inhibitory ef-
fects of p10 on BSA–NLS import in this experiment and
not stimulatory effects, we added Ran at a sufficiently high
concentration such that enough of it can enter the nucleus
by diffusion to support cNLS cargo import, thus diminish-
ing an observed stimulatory effect of p10 (Paschal et al.,
1997). As can be seen in Fig. 4 B, both wt and D23A p10
slightly stimulated the import of BSA–NLS when added at
a low concentration of 1 
 
m
 
M. However, with increasing
concentrations, D23A p10 rapidly inhibited the import of
BSA–NLS such that at 5 
 
m
 
M D23A p10, the inhibition was
almost complete. wt p10 also showed an inhibition of
BSA–NLS import at higher concentrations, but the inhibi-
tion was not yet complete at the highest concentration of
wt p10 tested (20 
 
m
 
M).
We found that D23A p10 has the same inhibitory effect
on BSA–NLS nuclear import in vivo as in permeabilized
cells (Fig. 5). We had determined previously that FITC–
Figure 2. Nuclear accumulation of FITC–RanGDP. (A) Digitonin-permeabilized BRL cells were incubated with 2 mM FITC–RanGDP
in TB containing 2 mg/ml BSA for 20 min at room temperature, washed, and fixed. All samples, except those labeled No Energy, also
contained 0.5 mM GTP, 1 mM ATP, 5 mM phosphocreatine, and 20 U/ml creatine phosphokinase. Where indicated, the following pro-
teins were also added: 1.0 mM wt p10 (dimer), and 0.25 mM Kap-b1 or Kap-b1(45–462). (B) Quantitation of the nuclear import of FITC–
RanGDP in digitonin-permeabilized BRL cells was performed as described in the Materials and Methods. All samples contained 1.5 mM
FITC–RanGDP and 2 mg/ml BSA in TB, and the import reaction was incubated for 15 min at room temperature before washing and fix-
ation. Individual samples also contained the indicated concentration of wt p10 dimer and: s, 0.5 mM GDP; d, 0.5 mM GTP; h, 0.5 mM
GTP 1 0.25 mM Kap-a2; and j, 0.5 mM GTP 1 0.25 mM Kap-b1. (C) Quantitation of the nuclear import obtained of FITC–RanGDP in
the presence of increasing concentrations of: s, WT p10; d, D23A p10; and j, E42D p10. In addition to 1.5 mM FITC–RanGDP, all the
samples contained 0.5 mM GTP, 0.25 mM Kap-b1, and 2 mg/ml BSA in TB. Import was for 7.5 min before washing and fixation. 
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RanGDP injected into the cytoplasm of HeLa cells could
be observed to rapidly (within 5 min) accumulate inside
the nucleus (data not shown). To simultaneously examine
the effects of the p10 mutants on Ran uptake and NLS-
mediated import, the following were coinjected into the
cytoplasm: FITC–RanGDP, TRITC–BSA–NLS, Cascade
blue–labeled BSA (marker), and unlabeled p10 (wt or mu-
tant). Neither the wt nor mutant p10s had any effect on the
nuclear accumulation of Ran when coinjected with it into
the cytoplasm (Fig. 5, left column); the injected cells would
of course contain endogenous wt p10. However, as seen
previously in the permeabilized cells, D23A p10 inhibited
the nuclear import of coinjected BSA–NLS at the same
time that the nuclear accumulation of coinjected Ran was
unaffected. As these whole cells at the time of injection
obviously contain enough nuclear Ran to support NLS-
mediated nuclear import, and also because this mutant ap-
pears fully capable of supporting Ran nuclear import in
vitro, we concluded that D23A p10 must be inhibiting
BSA–NLS import by a mechanism unrelated to the nu-
clear uptake of Ran.
The interaction of wt and mutant p10s with NPC com-
ponents was assessed using both endogenous, assembled
NPCs in permeabilized cells, and fragments of an individ-
ual repeat Nup (Nup98). HeLa cells were permeabilized
with digitonin and then incubated with purified wt or mu-
tant p10s. After washing and fixation, bound p10 was de-
tected by immunofluorescence microscopy with an anti-
FLAG antibody. As shown in Fig. 6 A, wt, E42A, and
D23A p10 added in buffer alone bound to the nuclear en-
velope of the permeabilized cells, however no binding of
Y19A p10 was observed. Strikingly, the D23A p10 gave
much more intense staining at the nuclear envelope than
wt p10. The pattern of staining was identical to that
achieved with mAb 414 (data not shown), which binds the
FXFG epitope present on a group of NPC proteins (Davis
and Blobel, 1986; Wente et al., 1992). Thus, D23A p10
showed increased binding to NPCs relative to wt p10.
p10 is known to bind to various repeat Nups and is also
known to be able to bind a repeat Nup and RanGDP at
the same time (Paschal and Gerace, 1995; Clarkson et al.,
1996; Nehrbass and Blobel, 1996). To compare the binding
of wt and mutant p10s to a specific repeat Nup, an overlay
assay was performed against various segments of the ver-
tebrate nucleoporin Nup98 (Fig. 6 B). The Nup98-1 con-
struct contains amino acids 43–824 of rat Nup98, Nup98-2
Figure 3. p10 mutants that cannot bind RanGDP do not support
nuclear accumulation of FITC–RanGDP in digitonin-permeabi-
lized cells. (A) Recombinant p10 proteins were dotted onto ni-
trocellulose, as described in the Materials and Methods, and the
nitrocellulose was incubated with either Ran[a-32P]GDP or
Ran[a-32P]GTP, washed, and exposed to film. (B) The ability of
different p10 mutants to mediate the import of FITC–RanGDP
(2  mM) in permeabilized
BRL cells was assayed, as de-
scribed in the legend to Fig.
2. Samples contained 0.5 mM
GTP, 1 mM ATP plus a re-
generating system, and 1 mM
of the indicated p10 protein
(dimer). Import was for 20
min at room temperature be-
fore washing and fixation.
Figure 4. D23A p10 is a dominant-negative inhibitor of the nu-
clear import of TRITC–BSA–NLS in vitro. (A) wt p10 or D23A
p10 (both at 3.0 mM dimer concentration) were added to an im-
port solution consisting of 10 mg/ml TRITC–BSA–NLS, 10 mg/ml
Xenopus ovarian cytosol, 0.5 mM GTP, and 1 mM ATP plus a re-
generating system. These mixtures were incubated with perme-
abilized BRL cells for 20 min at room temperature before wash-
ing and fixation. (B) The import assay was done as described in
A, except purified transport factors were used to support import,
rather than the cytosol, and the reaction was for 15 min. The im-
port reactions contained 10 mg/ml TRITC–BSA–NLS, 0.5 mM
Kap-a2, 0.25 mM Kap-b1, 2 mM RanGDP, 0.5 mM GTP, and 2
mg/ml BSA in addition to the indicated concentration of wt or
D23A p10 dimer.The Journal of Cell Biology, Volume 151, 2000 326
Figure 5. D23A p10 does not inhibit RanGDP nuclear accumulation, but does inhibit BSA–NLS nuclear accumulation in vivo. HeLa
cells were coinjected in the cytoplasm with the following: FITC–RanGDP (1 mg/ml), TRITC-BSA–NLS (2 mg/ml), the injection marker
Cascade blue–labeled BSA (Molecular Probes) (1 mg/ml), and unlabeled wt or mutant p10 (2.2 mg/ml). The cells were incubated 5 min
at room temperature after microinjection, and then fixed for observation.Lane et al. Selective Inhibition of Nuclear Import 327
contains amino acids 519–869, which does not contain re-
peats, and Nup 98-3 contains amino acids 43–518, which
includes 10 GLFG, 17 FG, and 3 FXFG repeats (Radu et
al., 1995b). The three Nup98 fragments were expressed in
E. coli and the bacterial lysates were separated by SDS-
PAGE. The separated proteins were transferred to nitro-
cellulose, overlaid with either wt or mutant p10, and
bound p10 protein was subsequently detected by immuno-
blotting. wt, E42D, and D23A p10 only bound to the por-
tion of Nup98 that contains repeats (Nup 98-1 and 98-3);
they did not bind to the half of Nup98 that does not con-
tain repeats (Nup 98-2) or to any of the endogenous E. coli
proteins also present. In contrast, there was no significant
binding of Y19A p10 to any of the Nup98 fragments, in
agreement with the NPC binding results we observed in
permeabilized cells (Fig. 6 A). p10 has been reported
to preferentially bind to FXFG-containing nucleoporins
rather than nucleoporins that contain only GLFG repeats
(Clarkson et al., 1997). Nup98 contains FXFG, GLFG, and
FG sequences within the region exhibiting p10 binding.
What Nup98 repeat sequences (if any) present in the
Nup98-3 construct was responsible for the observed p10
binding was not determined. Kap-b1, another nuclear car-
rier also known to bind repeat Nups, was shown previously
to exhibit the same binding pattern to these Nup98 frag-
ments as wt p10 (Radu et al., 1995b).
That D23A p10 exhibits increased binding to the NPC
relative to wt p10 shown again in Fig. 7. In this experiment,
0.25 mM (dimer) wt or mutant p10 was incubated with the
permeabilized cells either alone, or in the presence of 20
mM RanGDP, Kap-b1, or untagged p10. The observed
binding of p10 to the nuclear envelope appeared to be spe-
cific in that it could be abolished by inclusion of an excess
of wt p10 lacking the FLAG epitope (Fig. 7), although the
untagged wt p10 appeared somewhat less able to compete
away the binding of tagged D23A p10 than tagged wt p10.
Interestingly, the binding of wt p10 to NPCs was found to
be enhanced by the addition of RanGDP (Fig. 7). The
Figure 6. Interaction of p10 mutants with the NPC. (A) Digito-
nin-permeabilized HeLa cells were incubated with 0.25 mM
(dimer) wt or mutant p10, as described in the Materials and
Methods. After washing and fixation, the bound p10 was de-
tected by indirect immunofluorescence microscopy with an anti-
FLAG antibody followed by a TRITC-labeled anti–mouse sec-
ond antibody. (B) Diagram indicates the fragments of Nup98 that
were used in the overlay assay. Cell lysates from E. coli express-
ing different portions of the nucleoporin Nup98 (Nup98-1,
Nup98-2, and Nup98-3) were separated on a 10% SDS-PAGE
gel. Arrows indicate the migration position of the expressed
pieces of Nup98 after staining of a gel with Coomassie blue.
Other samples were transferred to nitrocellulose and overlaid
with 0.5 mM wt or mutant p10, as described in the Materials and
Methods. Bound p10 was detected by immunoblotting with an
anti-Express antibody.The Journal of Cell Biology, Volume 151, 2000 328
binding of D23A p10 to the NPC in the presence of Ran
may also have been marginally higher, but the high signal
in the absence of Ran made this determination difficult.
This phenomenon of Ran-enhanced p10 binding to the
NPC has been reported before (Ribbeck et al., 1998), and
is likely due to RanGDP binding sites at the NPC (see Dis-
cussion).
In contrast to the stimulatory effects of Ran on NPC
binding, the inclusion of an excess of Kap-b1 markedly in-
hibited the binding of both wt and D23A p10 to the NPC
(Fig. 7). Others have reported that p10 and Kap-b1 are ca-
pable of binding each other directly (Nehrbass and Blobel,
1996; Percipalle et al., 1997), but we have been unable to
demonstrate such an interaction (data not shown) consis-
tent with the findings of others (Paschal et al., 1996). In-
stead, we believe that the ability of Kap-b1 to inhibit p10
binding at the NPC indicates that the majority of binding
sites of p10 and Kap-b1 at the NPC are either identical, or
closely overlapping. We also believe that it is this competi-
tion for shared docking sites that explains the ability of
D23A p10 to inhibit Kap-b1-mediated cNLS import (see
Discussion). In the experiment shown in Fig. 7, 20 mM
Kap-b1 was able to greatly diminish any p10 binding when
added with 0.25 mM (dimer) p10. In experiments not
shown, we found that D23A p10 gave visible NPC binding
when Kap-b1 was included in only a tenfold molar excess
(rather than the 80-fold molar excess shown in Fig. 7),
however wt p10 still did not give visible NPC binding when
added with only a twofold molar excess of Kap-b1.
If Kap-b1 and p10 use many of the same docking sites to
move their respective cargoes across the NPC, then an ex-
cess of one carrier should inhibit the import of the other
carrier. As we have already shown in Fig. 2 C, increasing
concentrations of D23A or wt p10 do in fact inhibit the im-
port of a cNLS cargo that uses Kap-b1 as a carrier, with
D23A p10 showing a greatly increased ability to inhibit
relative to wt p10. Fig. 8 shows that the reverse is also true,
that increasing amounts of Kap-b1 will inhibit Ran import
mediated by p10. In this experiment, increasing amounts
of Kap-b1 were added together with wt or D23A p10 and
GTP to determine whether adding an excess of Kap-b1
will inhibit the p10-mediated import of FITC–RanGDP.
As already discussed, low concentrations of Kap-b1 stimu-
late p10-mediated Ran nuclear accumulation and this is
believed to be due to a trapping of Ran by Kap-b1 inside
the nucleus (Ribbeck et al., 1998). As shown in Fig. 8 (see
also Fig. 2 C), D23A p10 was measurably more efficient
than wt p10 at supporting Ran import when a low level
(2.5 mM) of Kap-b1 was present. However, with increasing
concentrations of Kap-b1, the nuclear accumulation of
Ran mediated by either wt or D23A p10 was progressively
inhibited (Fig. 8).
Discussion
We examined the effects of three different point muta-
tions (D23A, E42D, and Y19A) on the activity of the nu-
clear carrier p10. Surprisingly, we found that one of these
Figure 7. wt p10 and D23A p10 binding to the nuclear envelopes
of permeabilized cells in the presence of other nuclear transport
factors. Binding of wt and mutant p10 to the nuclear envelope of
digitonin-permeabilized HeLa cells was performed as described
in the legend to Fig. 6. 0.25 mM (dimer) wt p10 or D23A p10 were
added either alone (top), or with 20 mM RanGDP, 20 mM Kap-
b1, or 20 mM untagged wt p10.
Figure 8. Inhibition of RanGDP import by high concentrations of
Kap-b1. p10-mediated nuclear import of FITC–RanGDP was
measured in the presence of increasing concentrations of Kap-b1.
All samples contained 1.5 mM FITC–RanGDP, 0.5 mM GTP, 2
mg/ml BSA, and Kap-b1 at the indicated concentrations. In addi-
tion, samples contained 1.25 mM (dimer) WT p10 (s) or D23A
p10 (d). Import was for 15 min before washing and fixation.Lane et al. Selective Inhibition of Nuclear Import 329
mutations, D23A, markedly increased p10’s ability to me-
diate the nuclear import of its cargo RanGDP (Figs. 2 and
8). Even more surprisingly, we also found that D23A p10,
while importing its own cargo more efficiently than wt p10,
would inhibit the nuclear import of a cNLS cargo medi-
ated by a different nuclear carrier in a dominant-negative
fashion (Figs. 4 and 5). We further found that D23A p10
shows increased binding to the NPCs of permeabilized
cells when compared with wt p10 (Figs. 6 and 7). We be-
lieve that it is this increased NPC binding that is responsi-
ble for the ability of low concentrations of D23A p10 to in-
hibit cNLS import by diminishing the ability of the carrier
Kap-b1 to compete effectively for shared NPC docking
sites needed for the transport of cNLS cargo. At higher
concentrations, wt p10 is also inhibitory to cNLS import
(Fig. 4) (Tachibana et al., 1996), thus we believe that the
D23A mutation only increases the affinity of p10 for pre-
existing p10 NPC binding sites rather than causing p10 to
bind completely new sites.
Competition studies showed that p10 and Kap-b1 ap-
pear to use many of the same, or closely overlapping, NPC
docking sites for movement through the NPC. An excess
of Kap-b1 will block the binding of p10 to the NPC (Fig.
7), and an excess of either p10 (Fig. 4) or Kap-b1 (Fig. 8)
will inhibit both the import of their own cargo as well as
cargo transported by the other nuclear transport pathway.
Thus, our results support the conclusion that a carrier of
one class can compete with a carrier of another class for
transport, probably because of competition for shared
binding sites at the NPC.
To what extent do different nuclear carriers share dock-
ing sites at the NPC? Both biochemical and genetic data
have implicated the family of repeat Nups in mediating
Kap-b1 transport across the NPC (Iovine et al., 1995;
Radu et al., 1995a,b; Rexach and Blobel, 1995). Many of
the same repeat Nups that can bind Kap-b1 can also bind
p10 (though not necessarily at the same site), and other
members of the Kap-b family have been shown to bind the
same repeat Nups, as well (Aitchison et al., 1996; Nehrbass
and Blobel, 1996; Bonifaci et al., 1997; Pemberton et al.,
1997; Rosenblum et al., 1997; Rout et al., 1997; Nakielny et
al., 1999; Ullman et al., 1999; Yaseen and Blobel, 1999).
Görlich and coworkers engineered a truncated Kap-b1
lacking its Ran binding domain and showed that it accu-
mulates at NPCs and inhibits most nuclear transport path-
ways, including cNLS and M9-NLS cargo import as well as
the export of mRNAs, UsnRNAs, and leucine-rich NES-
containing proteins (Kutay et al., 1997b). Here we found
that a similar truncated Kap-b1 (45–462) also inhibits the
p10-mediated import of RanGDP (Fig. 2).
However, there is good evidence that not all carrier
binding sites at the NPC are exactly equivalent. Forbes
and coworkers showed that Nup153 binds two different
transport carriers (Kap-b1 and transportin/Kap-b2) at dif-
ferent sites of the Nup153 protein (Shah and Forbes,
1998). The Gerace laboratory found that the presence of a
100-fold molar excess of p10 did not interfere with the
binding of Kap-b1 to three different subunits of the p62
complex (p62, p58, and p54), all of which contain FG re-
peats (Hu et al., 1996). However, our data shows that in
the context of an assembled NPC, p10 is able to compete
with Kap-b1 for sites critical for the import of cNLS cargo
(Figs. 4 and 5). Görlich and coworkers also reported that
there appear to be at least two separate binding sites for
Kap-b1 at the NPC (Kutay et al., 1997a). At least one of
these sites affects p10 binding because we observed that
not only would Kap-b1 completely prevent p10 binding at
the NPC (Fig. 7), but that p10 bound at the NPC could be
completely displaced by the subsequent addition of Kap-
b1 (data not shown). These results may indicate that p10
and Kap-b1 binding sites at the NPC are overlapping, but
not identical, or it might indicate that these two proteins
can bind to the same sites but with different affinities. The
increased occupancy of these NPC sites by D23A p10
could result in Kap-b1 no longer being able to compete ef-
ficiently for shared docking sites, thereby inhibiting cNLS
import.
We hypothesize that all transport carriers of the Kap-b
or the p10-type are likely to use FG repeats as docking
sites at the NPC (heavily, but not necessarily exclusively)
and that the amino acids surrounding the FG repeat (such
as GLFG or FXFG) can raise or lower a particular car-
rier’s affinity for that docking site. In addition, larger sub-
strates might need more available NPC docking sites than
smaller ones during transport. This would explain results
that we obtained previously when we examined, by elec-
tron microscopy, the effects of microinjected p10 on the
ability of Xenopus NPCs to import cNLS–gold conjugates
of different sizes (Feldherr et al., 1998). Stage 2 Xenopus
oocytes begin to synthesize predominantly 18S and 28S
rRNA, rather than the mainly 5S RNA that is synthesized
in stage 1 oocytes. This shift is accompanied by an increase
in both the rate of nuclear transport and the size of parti-
cles able to move through the NPCs (Feldherr et al., 1998).
We found that microinjection of p10 into stage 2 oocytes
decreases the size of cNLS–gold particles able to be im-
ported through the NPC, such that their import capacity is
now identical to that of a stage 1 oocyte and that this effect
is dependent on the amount of p10 injected (Feldherr et
al., 1998). We concluded that the amount of p10 in the cell
may regulate the functional size of the NPC during oogen-
esis, but at the time we had no idea how this might be ac-
complished.
Now, we hypothesize that the observed decrease in the
size of cNLS–gold that could be imported after microinjec-
tion of p10 is directly related to the increased occupation
of docking sites at the NPC by p10 that are also needed by
Kap-b1 for cNLS import, and that a larger cargo likely
needs more empty carrier docking sites to sustain its
movement across the NPC than a smaller one. Here we
found that microinjected D23A p10 at 2.2 mg/ml into
HeLa cells inhibits the import of coinjected BSA–NLS,
but that wt p10 microinjected at the same concentration
does not (Fig. 5). Because D23A p10 shows increased
binding to the NPC relative to wt p10, microinjection of
equal concentrations of each would probably result in
more D23A p10 bound at the NPC than wt p10. However,
in additional experiments not shown, we found that if we
increased the microinjected concentration of each to 5 mg/
ml, both wt p10 as well as the D23A mutant would inhibit
BSA–NLS import. This is in agreement with the findings
of Yoneda and coworkers who found that microinjection
of p10 (5 mg/ml) into mammalian cells would inhibit both
the import of cNLS cargo and the export of leucine-richThe Journal of Cell Biology, Volume 151, 2000 330
NES cargo (Tachibana et al., 1996). If in the Xenopus oo-
cyte study we had microinjected a higher concentration of
p10 into the Xenopus oocytes than we did, our prediction
now would be that we would have observed a complete
shutdown of cNLS–gold import due to an increased occu-
pation of NPC binding sites (Feldherr et al., 1998).
In the crystal structure of p10, amino acid D23 forms an
in-line hydrogen bonded relay with another amino acid,
H66, which is located at the base of the hydrophobic cavity
that is the central feature of the p10 structure (Bullock et
al., 1996). Clarkson et al. (1997) showed that D23N p10 (as
opposed to the D23A mutant used here) is able to bind
both RanGDP and Nsp1p (an FXFG repeat containing
yeast nucleoporin), however the ability of D23N p10 to
support nuclear import was not determined. With regard
to p10’s NPC binding ability, an analysis of the p10 crystal
structure reveals a hydrophobic patch on the surface of the
p10 molecule (centered roughly around Trp7) that was
predicted by Stewart and coworkers to possibly interact
with the hydrophobic-aromatic side chains of an FXFG re-
peat (Bayliss et al., 1999). Accordingly, an amino acid con-
stituent of this hydrophobic patch was mutated (W7A)
and W7A p10 was shown to have decreased, but not abol-
ished, binding to an FXFG-containing piece of repeat Nup
p62. Experiments are in progress in our laboratory to de-
termine the crystal structure of D23A p10 to see what
structural changes resulting from this mutation could be
responsible for p10’s increased binding to the NPC.
Interestingly, a protein (p15/NXT1) that shows signifi-
cant homology to p10 was identified in HeLa cells and
shown to bind to the mRNA export factor TAP (Katahira
et al., 1999). p15, like p10, was shown to bind to the nuclear
envelope and, perhaps significantly, amino acid D23 (D29
in p15) is conserved between p10 and p15, although H66 is
not. The TAP–p15 complex was found to complement a
Mex67-Mtr2 double deletion in yeast (both of which have
been implicated in mRNA export), even though neither
Mex67p nor Mtr2p appear to be the yeast homologue of
p15, which does not in fact appear to have a yeast ho-
mologue at all. Unlike p10, which preferentially binds
RanGDP, p15 strongly and specifically binds RanGTP
(Black et al., 1999). Very recently, Dargemont and co-
workers reported that p15 strongly stimulates export of
U1snRNA, tRNA, and mRNA in an in vitro nuclear ex-
port assay in permeabilized HeLa cells, and that the ability
of p15 to stimulate export is dependent on its capacity to
bind RanGTP (Ossareh-Nazari et al., 2000). These results
indicate that p15, like p10, likely uses its NPC binding abil-
ity to facilitate the nuclear transport of cargo.
We feel that the results shown here raise the distinct
possibility that a cell could increase or decrease the rate of
transport of a particular cargo in response to a cellular sig-
nal by changing the affinity of a carrier for the NPC by, for
example, a posttranslational modification. Slightly chang-
ing the affinity of a carrier for its NPC docking sites could
substantially increase or decrease the rate of transport of
its cargo, both as measured directly and in relation to dif-
ferent cargoes, by altering that carrier’s ability to compete
with other carriers for shared docking sites. The effect of
our D23A mutation on p10 may be mimicking a naturally
occurring posttranslational modification that can affect
carrier function in vivo.
We have estimated the normal in vivo concentration of
p10 to be z106 molecules per HeLa cell (data not shown),
which would make p10 in HeLa cells z1/10th as abundant
as Ran (Bischoff and Ponstingl, 1991). As p10 is only one
of a large number of carriers capable of interacting with
the NPC, many of which are probably competing for the
same sites, even a slight change in the affinity of one for
shared docking sites could shift the equilibrium between
different nuclear transport pathways. Whether the rates of
nuclear transport inside a cell are in fact modulated by
such a change in nuclear carrier affinity for the NPC re-
mains undetermined, but we are examining this possibility.
We thank M. Rush, A. Lamond, D. Görlich, U. Grundmann, G. Blobel,
and S. Adam for expression plasmids and B. Schwartz for the use of his
microinjector. We also thank D. Hoffmaster and Q. Xie for excellent tech-
nical assistance and S. Mullican for additional p10 microinjection experi-
ments. We thank E. Schwoebel and B. Talcott for their help preparing
some of the figures and also for their comments on the manuscript.
This work was supported by a grant from the National Institutes of
Health (GM53678), the Searle Scholar/Chicago Community Trust, and
also by Reproductive Training Grant (CML) T32-HD07165.
Submitted: 28 June 2000
Revised: 22 August 2000
Accepted: 28 August 2000
References
Aitchison, J.D., G. Blobel, and M.P. Rout. 1996. Kap104p: a karyopherin in-
volved in the nuclear transport of messenger RNA binding proteins. Science.
274:624–627.
Bayliss, R., K. Ribbeck, D. Akin, H.M. Kent, C.M. Feldherr, D. Görlich, and
M. Stewart. 1999. Interaction between NTF2 and xFxFG-containing nucle-
oporins is required to mediate nuclear import of RanGDP. J. Mol. Biol. 293:
579–593.
Bischoff, F.R., and H. Ponstingl. 1991. Mitotic regulator protein RCC1 is com-
plexed with a nuclear ras-related polypeptide. Proc. Natl. Acad. Sci. USA.
88:10830–10834.
Black, B.E., L. Levesque, J.M. Holaska, T.C. Wood, and B.M. Paschal. 1999.
Identification of an NTF2-related factor that binds Ran-GTP and regulates
nuclear protein export. Mol. Cell. Biol. 19:8616–8624.
Bonifaci, N., J. Moroianu, A. Radu, and G. Blobel. 1997. Karyopherin b2 medi-
ates nuclear import of an mRNA binding protein. Proc. Natl. Acad. Sci.
USA. 94:5055–5060.
Bullock, T.L., W.D. Clarkson, H.M. Kent, and M. Stewart. 1996. The 1.6 ang-
stroms resolution crystal structure of nuclear transport factor 2 (NTF2). J.
Mol. Biol. 260:422–431.
Clarkson, W.D., A.H. Corbett, B.M. Paschal, H.M. Kent, A.J. McCoy, L. Ger-
ace, P.A. Silver, and M. Stewart. 1997. Nuclear protein import is decreased
by engineered mutants of nuclear transport factor 2 (NTF2) that do not bind
GDP-Ran. J. Mol. Biol. 272:716–730.
Clarkson, W.D., H.M. Kent, and M. Stewart. 1996. Separate binding sites on
nuclear transport factor 2 (NTF2) for GDP-Ran and the phenylalanine-rich
repeat regions of nucleoporins p62 and Nsp1p. J. Mol. Biol. 263:517–524.
Corbett, A.H., and P.A. Silver. 1996. The NTF2 gene encodes an essential,
highly conserved protein that functions in nuclear transport in vivo. J. Biol.
Chem. 271:18477–18484.
Davis, L.I., and G. Blobel. 1986. Identification and characterization of a nuclear
pore complex protein. Cell. 45:699–709.
Englmeier, L., J.C. Olivo, and I.W. Mattaj. 1999. Receptor-mediated substrate
translocation through the nuclear pore complex without nucleotide triphos-
phate hydrolysis. Curr. Biol. 9:30–41.
Feldherr, C., D. Akin, and M.S. Moore. 1998. The nuclear import factor p10
regulates the functional size of the nuclear pore complex during oogenesis. J.
Cell Sci. 111:1889–1896.
Floer, M., and G. Blobel. 1999. Putative reaction intermediates in Crm1-medi-
ated nuclear protein import. J. Biol. Chem. 274:16279–16286.
Floer, M., G. Blobel, and M. Rexach. 1997. Disassembly of RanGTP-karyo-
pherin b complex, an intermediate in nuclear protein import. J. Biol. Chem.
272:19538–19546.
Fornerod, M., J. van Deursen, S. van Baal, A. Reynolds, D. Davis, K.G. Murti,
J. Fransen, and G. Grosveld. 1997. The human homologue of yeast CRM1 is
in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore com-
ponent Nup88. EMBO (Eur. Mol. Biol. Organ.) J. 16:807–816.
Görlich, D., M. Dabrowski, F.R. Bischoff, U. Kutay, P. Bork, E. Hartmann, S.
Prehn, and E. Izaurralde. 1997. A novel class of RanGTP binding proteins. J.Lane et al. Selective Inhibition of Nuclear Import 331
Cell Biol. 138:65–80.
Görlich, D., N. Pante, U. Kutay, U. Aebi, and F.R. Bischoff. 1996. Identifica-
tion of different roles for RanGDP and RanGTP in nuclear protein import.
EMBO (Eur. Mol. Biol. Organ.) J. 15:5584–5594.
Hu, T., T. Guan, and L. Gerace. 1996. Molecular and functional characteriza-
tion of the p62 complex, an assembly of nuclear pore complex glycoproteins.
J. Cell Biol. 134:589–601.
Iovine, M.K., J.L. Watkins, and S.R. Wente. 1995. The GLFG repetitive region
of the nucleoporin Nup116p interacts with Kap95p, an essential yeast nu-
clear import factor. J. Cell Biol. 131:1699–1713.
Izaurralde E., U. Kutay, C. Von Kobbe, I.W. Mattaj, and D. Görlich. 1997. The
asymmetric distribution of the constituents of the Ran system is essential for
transport into and out of the nucleus. EMBO (Eur. Mol. Biol. Organ.) J. 16:
6535–6547.
Katahira, J., K. Strasser, A. Podtelejnikov, M. Mann, J.U. Jung, and E. Hurt.
1999. The Mex67p-mediated nuclear mRNA export pathway is conserved
from yeast to human. EMBO (Eur. Mol. Biol. Organ.) J. 18:2593–2609.
Kose, S., N. Imamoto, T. Tachibana, T. Shimamoto, and Y. Yoneda. 1997. Ran-
unassisted nuclear migration of a 97-kD component of nuclear pore-target-
ing complex. J. Cell Biol. 139:841–849.
Kutay, U., F.R. Bischoff, S. Kostka, R. Kraft, and D. Görlich. 1997a. Export of
importin a from the nucleus is mediated by a specific nuclear transport fac-
tor. Cell. 90:1061–1071.
Kutay, U., E. Izaurralde, F.R. Bischoff, I.W. Mattaj, and D. Görlich. 1997b.
Dominant-negative mutants of importin-b block multiple pathways of im-
port and export through the nuclear pore complex. EMBO (Eur. Mol. Biol.
Organ.) J. 16:1153–1163.
Kutay, U., G. Lipowsky, E. Izaurralde, F.R. Bischoff, P. Schwarzmaier, E.
Hartmann, and D. Görlich. 1998. Identification of a tRNA-specific nuclear
export receptor. Mol. Cell. 1:359–369.
Lanford, R.E., P. Kanda, and R.C. Kennedy. 1986. Induction of nuclear trans-
port with a synthetic peptide homologous to the SV40 T antigen transport
signal. Cell. 46:575–582.
Mahajan, R., C. Delphin, T. Guan, L. Gerace, and F. Melchior. 1997. A small
ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear
pore complex protein RanBP2. Cell. 88:97–107.
Matunis, M.J., E. Coutavas, and G. Blobel. 1996. A novel ubiquitin-like modifi-
cation modulates the partitioning of the Ran-GTPase-activating protein
RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol.
135:1457–1470.
Moore, M.S., and G. Blobel. 1992. The two steps of nuclear import, targeting to
the nuclear envelope and translocation through the nuclear pore, require
different cytosolic factors. Cell. 69:939–950.
Moore, M.S., and G. Blobel. 1994. Purification of a Ran-interacting protein that
is required for protein import into the nucleus. Proc. Natl. Acad. Sci. USA.
91:10212–10216.
Nakielny, S., and G. Dreyfuss. 1999. Transport of proteins and RNAs in and
out of the nucleus. Cell. 99:677–690.
Nakielny, S., S. Shaikh, B. Burke, and G. Dreyfuss. 1999. Nup153 is an M9-con-
taining mobile nucleoporin with a novel Ran-binding domain. EMBO (Eur.
Mol. Biol. Organ.) J. 18:1982–1995.
Nehrbass, U., and G. Blobel. 1996. Role of the nuclear transport factor p10 in
nuclear import. Science. 272:120–122.
Ohtsubo, M., H. Okazaki, and T. Nishimoto. 1989. The RCC1 protein, a regula-
tor for the onset of chromosome condensation, locates in the nucleus and
binds to DNA. J. Cell Biol. 109:1389–1397.
Ossareh-Nazari, B., C. Maison, B.E. Black, L. Levesque, B.M. Paschal, and C.
Dargemont. 2000. RanGTP-binding protein NXT1 facilitates nuclear export
of different classes of RNA in vitro. Mol. Cell Biol. 20:4562–4571.
Paschal, B.M., and L. Gerace. 1995. Identification of NTF2, a cytosolic factor
for nuclear import that interacts with nuclear pore complex protein p62. J.
Cell Biol. 129:925–937.
Paschal, B.M., C. Delphin, and L. Gerace. 1996. Nucleotide-specific interaction
of Ran/TC4 with nuclear transport factors NTF2 and p97. Proc. Natl. Acad.
Sci. USA. 93:7679–7683.
Paschal, B.M., C. Fritze, T. Guan, and L. Gerace. 1997. High levels of the GTP-
ase Ran/TC4 relieve the requirement for nuclear protein transport factor 2.
J. Biol. Chem. 272:21534–21539.
Pemberton, L.F., J.S. Rosenblum, and G. Blobel. 1997. A distinct and parallel
pathway for the nuclear import of an mRNA-binding protein. J. Cell Biol.
139:1645–1653.
Percipalle, P., W.D. Clarkson, H.M. Kent, D. Rhodes, and M. Stewart. 1997.
Molecular interactions between the importin a/b heterodimer and proteins
involved in vertebrate nuclear protein import. J. Mol. Biol. 266:722–732.
Radu, A., G. Blobel, and M.S. Moore. 1995a. Identification of a protein com-
plex that is required for nuclear protein import and mediates docking of im-
port substrate to distinct nucleoporins. Proc. Natl. Acad. Sci. USA. 92:1769–
1773.
Radu, A., M.S. Moore, and G. Blobel. 1995b. The peptide repeat domain of nu-
cleoporin Nup98 functions as a docking site in transport across the nuclear
pore complex. Cell. 81:215–222.
Ren, M., G. Drivas, P. D’Eustachio, and M.G. Rush. 1993. Ran/TC4: a small
nuclear GTP-binding protein that regulates DNA synthesis. J. Cell Biol. 120:
313–323.
Rexach, M., and G. Blobel. 1995. Protein import into nuclei: association and
dissociation reactions involving transport substrate, transport factors, and
nucleoporins. Cell. 83:683–692.
Ribbeck, K., G. Lipowsky, H.M. Kent, M. Stewart, and D. Görlich. 1998. NTF2
mediates nuclear import of Ran. EMBO (Eur. Mol. Biol. Organ.) J. 17:6587–
6598.
Rosenblum, J.S., L.F. Pemberton, and G. Blobel. 1997. A nuclear import path-
way for a protein involved in tRNA maturation. J. Cell Biol. 139:1655–1661.
Rout, M.P., G. Blobel, and J.D. Aitchison. 1997. A distinct nuclear import path-
way used by ribosomal proteins. Cell. 89:715–725.
Ryan, K.J., and S.R. Wente. 2000. The nuclear pore complex: a protein machine
bridging the nucleus and cytoplasm. Curr. Opin. Cell Biol. 12:361–371.
Schwoebel, E.D., B. Talcott, I. Cushman, and M.S. Moore. 1998. Ran-depen-
dent signal-mediated nuclear import does not require GTP hydrolysis by
Ran. J. Biol. Chem. 273:35170–35175.
Shah, S., and D.J. Forbes. 1998. Separate nuclear import pathways converge on
the nucleoporin nup153 and can be dissected with dominant-negative inhibi-
tors. Curr. Biol. 8:1376–1386.
Smith, A., A. Brownawell, and I.G. Macara. 1998. Nuclear import of Ran is me-
diated by the transport factor NTF2. Curr. Biol. 8:1403–1406.
Stewart, M., H.M. Kent, and A.J. McCoy. 1998. Structural basis for molecular
recognition between nuclear transport factor 2 (NTF2) and the GDP-bound
form of the Ras-family GTPase Ran. J. Mol. Biol. 277:635–646.
Tachibana, T., M. Hieda, T. Sekimoto, and Y. Yoneda. 1996. Exogenously in-
jected nuclear import factor p10/NTF2 inhibits signal- mediated nuclear im-
port and export of proteins in living cells. FEBS Lett. 397:177–182.
Talcott, B., and M.S. Moore. 1999. Getting across the nuclear pore complex.
Trends Cell Biol. 9:312–318.
Ullman, K.S., S. Shah, M.A. Powers, and D.J. Forbes. 1999. The nucleoporin
nup153 plays a critical role in multiple types of nuclear export. Mol. Biol.
Cell. 10:649–664.
Wente, S.R., M.P. Rout, and G. Blobel. 1992. A new family of yeast nuclear
pore complex proteins. J. Cell Biol. 119:705–723.
Wong, D.H., A.H. Corbett, H.M. Kent, M. Stewart, and P.A. Silver. 1997. Inter-
action between the small GTPase Ran/Gsp1p and Ntf2p is required for nu-
clear transport. Mol. Cell. Biol. 17:3755–3767.
Yaseen, N.R., and G. Blobel. 1999. Two distinct classes of Ran-binding sites on
the nucleoporin Nup-358. Proc. Natl. Acad. Sci. USA. 96:5516–5521.